CRESCENT BIOPHARMA, INC. (Nasdaq:CBIO)

Health Care/Life Sciences • Biotechnology

CIK 1253689

Company

GlycoMimetics, Inc. is a biotechnology company, which engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. The company was founded by Rachel K. King and John L. Magnani on April 4, 2003 and is headquartered in Rockville, MD.

Address
9708 Medical Center Drive
Rockville, Maryland 20850

Employees
35

Stock Info

Close
$0.2672

Day Range
0.2414 - 0.2727

52 Week Range
0.1406 - 3.1800

Average volume
1.51M

Short Interest
2.2M (02/14/25)

% of Float Shorted
3.93%

Market Cap
$17.24M

Revenue
$10K

Net Income
-$36.9M

2020 Sales Growth
N/A

Rev. per Employee
N/A

P/E Ratio
N/A

EPS
-$0.5875

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

Chairman
Timothy R. Pearson

Independent Director
Patricia S. Andrews

Independent Director
Daniel M. Junius

SEC filings

Date	Form	Event
27 Nov, 2024	SC 13G
13 Nov, 2024	10-Q
12 Nov, 2024	SC 13G/A
7 Nov, 2024	8-K
7 Nov, 2024	DEFA14A
6 Nov, 2024	SC 13G
4 Nov, 2024	SC 13D
4 Nov, 2024	SCHEDULE 1
29 Oct, 2024	8-K
29 Oct, 2024	DEFA14A
15 Aug, 2024	SC 13G/A
14 Aug, 2024	SCHEDULE 1
9 Aug, 2024	4
8 Aug, 2024	10-Q
7 Aug, 2024	4
5 Aug, 2024	4
30 Jul, 2024	8-K
30 Jul, 2024	4
29 Jul, 2024	3
29 Jul, 2024	SC 13G/A
26 Jun, 2024	8-K
24 Jun, 2024	4
20 Jun, 2024	4
13 Jun, 2024	8-K
4 Jun, 2024	8-K
9 May, 2024	10-Q
8 May, 2024	SC 13D/A
6 May, 2024	8-K
2 May, 2024	8-K
1 May, 2024	4
1 May, 2024	4
1 May, 2024	4
1 May, 2024	4
1 May, 2024	4
1 May, 2024	4
1 May, 2024	4
2 Apr, 2024	4
2 Apr, 2024	4
2 Apr, 2024	4
1 Apr, 2024	ARS
1 Apr, 2024	DEF 14A
27 Mar, 2024	8-K
27 Mar, 2024	10-K
27 Mar, 2024	S-8
22 Mar, 2024	PRE 14A
1 Mar, 2024	8-K
29 Feb, 2024	SC 13D/A
12 Feb, 2024	SC 13D/A
9 Feb, 2024	SC 13G/A
29 Jan, 2024	SC 13G/A
17 Jan, 2024	4
17 Jan, 2024	4
17 Jan, 2024	4
17 Jan, 2024	4
17 Jan, 2024	4
2 Jan, 2024	8-K
2 Jan, 2024	4
2 Jan, 2024	4
2 Jan, 2024	4
3 Nov, 2023	10-Q
3 Nov, 2023	8-K
3 Oct, 2023	4
3 Oct, 2023	4
3 Oct, 2023	4
25 Sep, 2023	4
2 Aug, 2023	10-Q
2 Aug, 2023	8-K
2 Jun, 2023	4
22 May, 2023	8-K
22 May, 2023	4
22 May, 2023	4
22 May, 2023	4
22 May, 2023	4
22 May, 2023	4
22 May, 2023	4
22 May, 2023	4
18 May, 2023	4
17 May, 2023	144
11 May, 2023	4
9 May, 2023	4
3 May, 2023	10-Q
3 May, 2023	8-K
21 Apr, 2023	8-K
21 Apr, 2023	DEF 14A
21 Apr, 2023	ARS
31 Mar, 2023	3
31 Mar, 2023	3
29 Mar, 2023	S-8
29 Mar, 2023	8-K
29 Mar, 2023	10-K
10 Mar, 2023	8-K
2 Mar, 2023	8-K
28 Feb, 2023	4
23 Feb, 2023	4
21 Feb, 2023	8-K
17 Feb, 2023	4
13 Feb, 2023	3
13 Feb, 2023	4
13 Feb, 2023	SC 13G
10 Feb, 2023	SC 13D/A
6 Feb, 2023	5
30 Jan, 2023	4
27 Jan, 2023	4
20 Jan, 2023	4
20 Jan, 2023	4
20 Jan, 2023	4
6 Jan, 2023	4
4 Jan, 2023	4
27 Dec, 2022	4
18 Nov, 2022	4
16 Nov, 2022	4
14 Nov, 2022	4
14 Nov, 2022	4
14 Nov, 2022	4
14 Nov, 2022	4
14 Nov, 2022	4
9 Nov, 2022	10-Q
9 Nov, 2022	8-K
4 Oct, 2022	8-K
7 Sep, 2022	3
7 Sep, 2022	4
3 Aug, 2022	8-K
3 Aug, 2022	10-Q
3 Jun, 2022	8-K
20 May, 2022	4
20 May, 2022	8-K
20 May, 2022	4
20 May, 2022	4
20 May, 2022	4
20 May, 2022	4
20 May, 2022	4
20 May, 2022	4
28 Apr, 2022	424B5
28 Apr, 2022	8-K
28 Apr, 2022	10-Q
22 Apr, 2022	EFFECT
20 Apr, 2022	CORRESP
11 Apr, 2022	DEF 14A
10 Mar, 2022	UPLOAD
10 Mar, 2022	4
10 Mar, 2022	4
10 Mar, 2022	4
4 Mar, 2022	S-3
3 Mar, 2022	10-K
3 Mar, 2022	8-K
3 Mar, 2022	S-8
10 Feb, 2022	SC 13G/A
27 Jan, 2022	8-K
25 Jan, 2022	4
25 Jan, 2022	4
25 Jan, 2022	4
25 Jan, 2022	4
18 Nov, 2021	4
2 Nov, 2021	8-K
2 Nov, 2021	10-Q
10 Aug, 2021	3
5 Aug, 2021	8-K	CEO Change
5 Aug, 2021	10-Q
12 Jul, 2021	SC 13G/A
27 May, 2021	4
27 May, 2021	4
27 May, 2021	4
27 May, 2021	4
27 May, 2021	4
27 May, 2021	4
20 May, 2021	8-K
3 May, 2021	8-K
3 May, 2021	10-Q
5 Apr, 2021	DEF 14A
8 Mar, 2021	3
2 Mar, 2021	10-K
2 Mar, 2021	8-K
2 Mar, 2021	S-8
23 Feb, 2021	8-K
16 Feb, 2021	SC 13G/A
12 Feb, 2021	SC 13G/A
11 Feb, 2021	SC 13G/A
10 Feb, 2021	SC 13G
29 Jan, 2021	SC 13G/A
22 Jan, 2021	4
22 Jan, 2021	4
22 Jan, 2021	4
22 Jan, 2021	4
22 Jan, 2021	4

Last update:2025-03-06 13:14:47.870625

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.